Zhiguo Hou

Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer

Zhenyu Lin, Ming Cai, Peng Zhang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 160 citations · Full text

Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial

Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · 144 citations · Full text

Surgical Oncology, Esophageal Cancer, Neoadjuvant Therapy +16

Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)

Hongyun Zhao, Wenxiu Yao, Xuhong Min et al. · Journal of Thoracic Oncology · 2021 · 116 citations

Apatinib Plus Gefitinib, Medicine, Advanced Egfr-mutant Nsclc +8

Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer

Yansong Lin, Shukui Qin, Zhiyong Li et al. · JAMA Oncology · 2021 · 88 citations · Full text

Camrelizumab plus apatinib as second-line treatment for advanced oesophageal squamous cell carcinoma (CAP 02): a single-arm, open-label, phase 2 trial

Xiangrui Meng, Tao Wu, Yonggui Hong et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 82 citations

Second-line Treatment, Oncology, Esophageal Cancer +6